MedPath

VISCOFAN SA

🇪🇸Spain
Ownership
-
Employees
-
Market Cap
-
Website

Safety and Efficacy of Epicardial Implantation of Collagen Membranes With Allogeneic Adipose Derived Stem Cells

Phase 1
Not yet recruiting
Conditions
CABG-patients
Heart Failure
Myocardial Infarction (MI)
First Posted Date
2025-05-04
Last Posted Date
2025-05-04
Lead Sponsor
Viscofan
Target Recruit Count
10
Registration Number
NCT06956807
Locations
🇵🇱

Górnośląskie Centrum Medyczne im. prof. Leszka Gieca Śląskiego Uniwersytetu Medycznego w Katowicach, Katowice - Ochojec, Poland

First in Humans to Evaluate Collagen Patches With Stem Cells in Patients With Ischemic Left Ventricular Dysfunction

Phase 1
Conditions
Heart Failure With Reduced Ejection Fraction
Interventions
Device: VB-C01
First Posted Date
2018-11-20
Last Posted Date
2018-11-20
Lead Sponsor
Viscofan
Target Recruit Count
10
Registration Number
NCT03746938
Locations
🇪🇸

Clínica Universidad de Navarra, Pamplona, Navarra, Spain

🇪🇸

Hospital General Universitario Gregorio Marañón, Madrid, Spain

© Copyright 2025. All Rights Reserved by MedPath